28 August 2023>: Clinical Research
Impaired Renal Vein Flow in Atrial Fibrillation: A Potential Risk for Renal Dysfunction
Bayram Öztürk 1ABEF , Kemal Göçer 2ADE* , Ekrem Aksu 2ACD , Kamil Doğan 3ABEDOI: 10.12659/MSM.941435
Med Sci Monit 2023; 29:e941435
Table 6 Analysis of variables that may affect the presence of high RVSI.
B | β | *p | 95% Cl | ||
---|---|---|---|---|---|
Lower | Upper | ||||
Creatine | 0.371 | 1.449 | 0.692 | 0.231 | 9.087 |
Pro-BNP | 0.000 | 1.000 | 0.402 | 0.999 | 1.000 |
sPAP | 0.055 | 1.057 | 0.110 | 0.988 | 1.130 |
LVEF | 0.068 | 1.070 | 0.433 | 0.903 | 1.269 |
Presence of AF | 2.649 | 14.134 | 2.083 | 71.277 | |
Diabetes mellitus | −0.670 | 0.512 | 0.395 | 0.110 | 2.393 |
Hypertension | 0.324 | 1.383 | 0.679 | 0.297 | 6.433 |
p * Multivariate regression analysis. LVEF – left ventricular ejection fraction; RVSI – renal venous stasis index; Pro-BNP – pro-brain natriuretic peptide. |